SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-095204
Filing Date
2018-03-26
Accepted
2018-03-26 09:30:33
Documents
4
Period of Report
2018-05-07
Effectiveness Date
2018-03-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d545952ddef14a.htm DEF 14A 295688
2 GRAPHIC g545952g42h06.jpg GRAPHIC 123205
3 GRAPHIC g545952g45t66.jpg GRAPHIC 107850
4 GRAPHIC g545952g88h00.jpg GRAPHIC 1906
  Complete submission text file 0001193125-18-095204.txt   618103
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36327 | Film No.: 18711762
SIC: 2834 Pharmaceutical Preparations